11β-Prostaglandin F2α Ethanolamide – 5 mg

Brand:
Cayman
CAS:
714966-38-8
Storage:
-20
UN-No:
De Minimis - 1170 / 3

11β-Prostaglandin F2α ethanolamide (11β-PGF2α-EA) is the theoretical hepatic metabolite of PGD2-EA, produced during COX-2 metabolism of the endogenous cannabinoid AEA which is found in brain, liver, and other mammalian tissues.{2415} AEA can be used directly by COX-2 and specific PG synthase to produce ethanolamide congeners of the classical PGs.{5089,11045} PGD2-EA is formed in activated RAW 264.7 cells treated with AEA.{11045}  

 

Out of stock

SKU: - Category:

Description

11β-PGF2α-EA is the theoretical hepatic metabolite of PGD2-EA, produced during COX-2 metabolism of the endogenous cannabinoid AEA which is found in brain, liver, and other mammalian tissues.{2415} AEA can be used directly by COX-2 and specific PG synthase to produce ethanolamide congeners of the classical PGs.{5089,11045} PGD2-EA is formed in activated RAW 264.7 cells treated with AEA.{11045}


Formal name: N-(2-hydroxyethyl)-9α,11β,15S-trihydroxy-prosta-5Z,13E-dien-1-amide

Synonyms:  11-epi PGF2α-EA|11β-PGF2α-EA

Molecular weight: 397.6

CAS: 714966-38-8

Purity: ≥95%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids